1 Study Coverage
1.1 Vigabatrin Product Introduction
1.2 Market by Type
1.2.1 Global Vigabatrin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablet
1.2.3 Powder
1.3 Market by Application
1.3.1 Global Vigabatrin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infantile Spasms (IS)
1.3.3 Partial-Onset Seizures
1.3.4 Refractory Complex Partial Seizures
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vigabatrin Sales Estimates and Forecasts 2017-2028
2.2 Global Vigabatrin Revenue Estimates and Forecasts 2017-2028
2.3 Global Vigabatrin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vigabatrin Sales by Region
2.4.1 Global Vigabatrin Sales by Region (2017-2022)
2.4.2 Global Sales Vigabatrin by Region (2023-2028)
2.5 Global Vigabatrin Revenue by Region
2.5.1 Global Vigabatrin Revenue by Region (2017-2022)
2.5.2 Global Vigabatrin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vigabatrin Sales by Manufacturers
3.1.1 Global Top Vigabatrin Manufacturers by Sales (2017-2022)
3.1.2 Global Vigabatrin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vigabatrin in 2021
3.2 Global Vigabatrin Revenue by Manufacturers
3.2.1 Global Vigabatrin Revenue by Manufacturers (2017-2022)
3.2.2 Global Vigabatrin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vigabatrin Revenue in 2021
3.3 Global Vigabatrin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vigabatrin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vigabatrin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vigabatrin Sales by Type
4.1.1 Global Vigabatrin Historical Sales by Type (2017-2022)
4.1.2 Global Vigabatrin Forecasted Sales by Type (2023-2028)
4.1.3 Global Vigabatrin Sales Market Share by Type (2017-2028)
4.2 Global Vigabatrin Revenue by Type
4.2.1 Global Vigabatrin Historical Revenue by Type (2017-2022)
4.2.2 Global Vigabatrin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vigabatrin Revenue Market Share by Type (2017-2028)
4.3 Global Vigabatrin Price by Type
4.3.1 Global Vigabatrin Price by Type (2017-2022)
4.3.2 Global Vigabatrin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vigabatrin Sales by Application
5.1.1 Global Vigabatrin Historical Sales by Application (2017-2022)
5.1.2 Global Vigabatrin Forecasted Sales by Application (2023-2028)
5.1.3 Global Vigabatrin Sales Market Share by Application (2017-2028)
5.2 Global Vigabatrin Revenue by Application
5.2.1 Global Vigabatrin Historical Revenue by Application (2017-2022)
5.2.2 Global Vigabatrin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vigabatrin Revenue Market Share by Application (2017-2028)
5.3 Global Vigabatrin Price by Application
5.3.1 Global Vigabatrin Price by Application (2017-2022)
5.3.2 Global Vigabatrin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vigabatrin Market Size by Type
6.1.1 North America Vigabatrin Sales by Type (2017-2028)
6.1.2 North America Vigabatrin Revenue by Type (2017-2028)
6.2 North America Vigabatrin Market Size by Application
6.2.1 North America Vigabatrin Sales by Application (2017-2028)
6.2.2 North America Vigabatrin Revenue by Application (2017-2028)
6.3 North America Vigabatrin Market Size by Country
6.3.1 North America Vigabatrin Sales by Country (2017-2028)
6.3.2 North America Vigabatrin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Vigabatrin Market Size by Type
7.1.1 Europe Vigabatrin Sales by Type (2017-2028)
7.1.2 Europe Vigabatrin Revenue by Type (2017-2028)
7.2 Europe Vigabatrin Market Size by Application
7.2.1 Europe Vigabatrin Sales by Application (2017-2028)
7.2.2 Europe Vigabatrin Revenue by Application (2017-2028)
7.3 Europe Vigabatrin Market Size by Country
7.3.1 Europe Vigabatrin Sales by Country (2017-2028)
7.3.2 Europe Vigabatrin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vigabatrin Market Size by Type
8.1.1 Asia Pacific Vigabatrin Sales by Type (2017-2028)
8.1.2 Asia Pacific Vigabatrin Revenue by Type (2017-2028)
8.2 Asia Pacific Vigabatrin Market Size by Application
8.2.1 Asia Pacific Vigabatrin Sales by Application (2017-2028)
8.2.2 Asia Pacific Vigabatrin Revenue by Application (2017-2028)
8.3 Asia Pacific Vigabatrin Market Size by Region
8.3.1 Asia Pacific Vigabatrin Sales by Region (2017-2028)
8.3.2 Asia Pacific Vigabatrin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Vigabatrin Market Size by Type
9.1.1 Latin America Vigabatrin Sales by Type (2017-2028)
9.1.2 Latin America Vigabatrin Revenue by Type (2017-2028)
9.2 Latin America Vigabatrin Market Size by Application
9.2.1 Latin America Vigabatrin Sales by Application (2017-2028)
9.2.2 Latin America Vigabatrin Revenue by Application (2017-2028)
9.3 Latin America Vigabatrin Market Size by Country
9.3.1 Latin America Vigabatrin Sales by Country (2017-2028)
9.3.2 Latin America Vigabatrin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vigabatrin Market Size by Type
10.1.1 Middle East and Africa Vigabatrin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vigabatrin Revenue by Type (2017-2028)
10.2 Middle East and Africa Vigabatrin Market Size by Application
10.2.1 Middle East and Africa Vigabatrin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vigabatrin Revenue by Application (2017-2028)
10.3 Middle East and Africa Vigabatrin Market Size by Country
10.3.1 Middle East and Africa Vigabatrin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vigabatrin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Vigabatrin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Benta Pharma Industries
11.2.1 Benta Pharma Industries Corporation Information
11.2.2 Benta Pharma Industries Overview
11.2.3 Benta Pharma Industries Vigabatrin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Benta Pharma Industries Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Benta Pharma Industries Recent Developments
11.3 Dr. Fisher Farma
11.3.1 Dr. Fisher Farma Corporation Information
11.3.2 Dr. Fisher Farma Overview
11.3.3 Dr. Fisher Farma Vigabatrin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Dr. Fisher Farma Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dr. Fisher Farma Recent Developments
11.4 Lundbeck
11.4.1 Lundbeck Corporation Information
11.4.2 Lundbeck Overview
11.4.3 Lundbeck Vigabatrin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lundbeck Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lundbeck Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Vigabatrin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Perrigo
11.6.1 Perrigo Corporation Information
11.6.2 Perrigo Overview
11.6.3 Perrigo Vigabatrin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Perrigo Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Perrigo Recent Developments
11.7 Grindeks
11.7.1 Grindeks Corporation Information
11.7.2 Grindeks Overview
11.7.3 Grindeks Vigabatrin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Grindeks Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Grindeks Recent Developments
11.8 Endo International
11.8.1 Endo International Corporation Information
11.8.2 Endo International Overview
11.8.3 Endo International Vigabatrin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Endo International Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Endo International Recent Developments
11.9 Amneal Pharma
11.9.1 Amneal Pharma Corporation Information
11.9.2 Amneal Pharma Overview
11.9.3 Amneal Pharma Vigabatrin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Amneal Pharma Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amneal Pharma Recent Developments
11.10 Cipla
11.10.1 Cipla Corporation Information
11.10.2 Cipla Overview
11.10.3 Cipla Vigabatrin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Cipla Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cipla Recent Developments
11.11 Upsher-Smith
11.11.1 Upsher-Smith Corporation Information
11.11.2 Upsher-Smith Overview
11.11.3 Upsher-Smith Vigabatrin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Upsher-Smith Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Upsher-Smith Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vigabatrin Industry Chain Analysis
12.2 Vigabatrin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vigabatrin Production Mode & Process
12.4 Vigabatrin Sales and Marketing
12.4.1 Vigabatrin Sales Channels
12.4.2 Vigabatrin Distributors
12.5 Vigabatrin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vigabatrin Industry Trends
13.2 Vigabatrin Market Drivers
13.3 Vigabatrin Market Challenges
13.4 Vigabatrin Market Restraints
14 Key Findings in The Global Vigabatrin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Vigabatrin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Powder
Table 4. Global Vigabatrin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Vigabatrin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Vigabatrin Sales by Region (2017-2022) & (K Units)
Table 7. Global Vigabatrin Sales Market Share by Region (2017-2022)
Table 8. Global Vigabatrin Sales by Region (2023-2028) & (K Units)
Table 9. Global Vigabatrin Sales Market Share by Region (2023-2028)
Table 10. Global Vigabatrin Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Vigabatrin Revenue Market Share by Region (2017-2022)
Table 12. Global Vigabatrin Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Vigabatrin Revenue Market Share by Region (2023-2028)
Table 14. Global Vigabatrin Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Vigabatrin Sales Share by Manufacturers (2017-2022)
Table 16. Global Vigabatrin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Vigabatrin Revenue Share by Manufacturers (2017-2022)
Table 18. Vigabatrin Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Vigabatrin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Vigabatrin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vigabatrin as of 2021)
Table 21. Vigabatrin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Vigabatrin Product Offered
Table 23. Date of Manufacturers Enter into Vigabatrin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vigabatrin Sales by Type (2017-2022) & (K Units)
Table 26. Global Vigabatrin Sales by Type (2023-2028) & (K Units)
Table 27. Global Vigabatrin Sales Share by Type (2017-2022)
Table 28. Global Vigabatrin Sales Share by Type (2023-2028)
Table 29. Global Vigabatrin Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Vigabatrin Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Vigabatrin Revenue Share by Type (2017-2022)
Table 32. Global Vigabatrin Revenue Share by Type (2023-2028)
Table 33. Vigabatrin Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Vigabatrin Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Vigabatrin Sales by Application (2017-2022) & (K Units)
Table 36. Global Vigabatrin Sales by Application (2023-2028) & (K Units)
Table 37. Global Vigabatrin Sales Share by Application (2017-2022)
Table 38. Global Vigabatrin Sales Share by Application (2023-2028)
Table 39. Global Vigabatrin Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Vigabatrin Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Vigabatrin Revenue Share by Application (2017-2022)
Table 42. Global Vigabatrin Revenue Share by Application (2023-2028)
Table 43. Vigabatrin Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Vigabatrin Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Vigabatrin Sales by Type (2017-2022) & (K Units)
Table 46. North America Vigabatrin Sales by Type (2023-2028) & (K Units)
Table 47. North America Vigabatrin Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Vigabatrin Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Vigabatrin Sales by Application (2017-2022) & (K Units)
Table 50. North America Vigabatrin Sales by Application (2023-2028) & (K Units)
Table 51. North America Vigabatrin Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Vigabatrin Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Vigabatrin Sales by Country (2017-2022) & (K Units)
Table 54. North America Vigabatrin Sales by Country (2023-2028) & (K Units)
Table 55. North America Vigabatrin Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Vigabatrin Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Vigabatrin Sales by Type (2017-2022) & (K Units)
Table 58. Europe Vigabatrin Sales by Type (2023-2028) & (K Units)
Table 59. Europe Vigabatrin Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Vigabatrin Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Vigabatrin Sales by Application (2017-2022) & (K Units)
Table 62. Europe Vigabatrin Sales by Application (2023-2028) & (K Units)
Table 63. Europe Vigabatrin Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Vigabatrin Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Vigabatrin Sales by Country (2017-2022) & (K Units)
Table 66. Europe Vigabatrin Sales by Country (2023-2028) & (K Units)
Table 67. Europe Vigabatrin Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Vigabatrin Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Vigabatrin Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Vigabatrin Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Vigabatrin Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Vigabatrin Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Vigabatrin Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Vigabatrin Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Vigabatrin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Vigabatrin Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Vigabatrin Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Vigabatrin Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Vigabatrin Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Vigabatrin Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Vigabatrin Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Vigabatrin Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Vigabatrin Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Vigabatrin Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Vigabatrin Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Vigabatrin Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Vigabatrin Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Vigabatrin Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Vigabatrin Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Vigabatrin Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Vigabatrin Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Vigabatrin Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Vigabatrin Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Vigabatrin Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Vigabatrin Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Vigabatrin Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Vigabatrin Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Vigabatrin Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Vigabatrin Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Vigabatrin Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Vigabatrin Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Vigabatrin Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Vigabatrin Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Vigabatrin Revenue by Country (2023-2028) & (US$ Million)
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Sanofi Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Sanofi Recent Developments
Table 110. Benta Pharma Industries Corporation Information
Table 111. Benta Pharma Industries Description and Major Businesses
Table 112. Benta Pharma Industries Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Benta Pharma Industries Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Benta Pharma Industries Recent Developments
Table 115. Dr. Fisher Farma Corporation Information
Table 116. Dr. Fisher Farma Description and Major Businesses
Table 117. Dr. Fisher Farma Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Dr. Fisher Farma Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Dr. Fisher Farma Recent Developments
Table 120. Lundbeck Corporation Information
Table 121. Lundbeck Description and Major Businesses
Table 122. Lundbeck Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Lundbeck Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Lundbeck Recent Developments
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Novartis Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Novartis Recent Developments
Table 130. Perrigo Corporation Information
Table 131. Perrigo Description and Major Businesses
Table 132. Perrigo Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Perrigo Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Perrigo Recent Developments
Table 135. Grindeks Corporation Information
Table 136. Grindeks Description and Major Businesses
Table 137. Grindeks Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Grindeks Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Grindeks Recent Developments
Table 140. Endo International Corporation Information
Table 141. Endo International Description and Major Businesses
Table 142. Endo International Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Endo International Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Endo International Recent Developments
Table 145. Amneal Pharma Corporation Information
Table 146. Amneal Pharma Description and Major Businesses
Table 147. Amneal Pharma Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Amneal Pharma Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Amneal Pharma Recent Developments
Table 150. Cipla Corporation Information
Table 151. Cipla Description and Major Businesses
Table 152. Cipla Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Cipla Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Cipla Recent Developments
Table 155. Upsher-Smith Corporation Information
Table 156. Upsher-Smith Description and Major Businesses
Table 157. Upsher-Smith Vigabatrin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Upsher-Smith Vigabatrin Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Upsher-Smith Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Vigabatrin Distributors List
Table 163. Vigabatrin Customers List
Table 164. Vigabatrin Market Trends
Table 165. Vigabatrin Market Drivers
Table 166. Vigabatrin Market Challenges
Table 167. Vigabatrin Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Vigabatrin Product Picture
Figure 3. Global Vigabatrin Market Share by Type in 2021 & 2028
Figure 3. Tablet Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Vigabatrin Market Share by Application in 2021 & 2028
Figure 6. Infantile Spasms (IS)
Figure 7. Partial-Onset Seizures
Figure 8. Refractory Complex Partial Seizures
Figure 9. Vigabatrin Report Years Considered
Figure 10. Global Vigabatrin Sales 2017-2028 (K Units)
Figure 11. Global Vigabatrin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Vigabatrin Revenue 2017-2028 (US$ Million)
Figure 13. Global Vigabatrin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Vigabatrin Sales Market Share by Region (2017-2022)
Figure 15. Global Vigabatrin Sales Market Share by Region (2023-2028)
Figure 16. North America Vigabatrin Sales YoY (2017-2028) & (K Units)
Figure 17. North America Vigabatrin Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Vigabatrin Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Vigabatrin Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Vigabatrin Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Vigabatrin Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Vigabatrin Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Vigabatrin Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Vigabatrin Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Vigabatrin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Vigabatrin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Vigabatrin in the World: Market Share by Vigabatrin Revenue in 2021
Figure 28. Global Vigabatrin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Vigabatrin Sales Market Share by Type (2017-2028)
Figure 30. Global Vigabatrin Revenue Market Share by Type (2017-2028)
Figure 31. Global Vigabatrin Sales Market Share by Application (2017-2028)
Figure 32. Global Vigabatrin Revenue Market Share by Application (2017-2028)
Figure 33. North America Vigabatrin Sales Market Share by Type (2017-2028)
Figure 34. North America Vigabatrin Revenue Market Share by Type (2017-2028)
Figure 35. North America Vigabatrin Sales Market Share by Application (2017-2028)
Figure 36. North America Vigabatrin Revenue Market Share by Application (2017-2028)
Figure 37. North America Vigabatrin Sales Share by Country (2017-2028)
Figure 38. North America Vigabatrin Revenue Share by Country (2017-2028)
Figure 39. United States Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Vigabatrin Sales Market Share by Type (2017-2028)
Figure 42. Europe Vigabatrin Revenue Market Share by Type (2017-2028)
Figure 43. Europe Vigabatrin Sales Market Share by Application (2017-2028)
Figure 44. Europe Vigabatrin Revenue Market Share by Application (2017-2028)
Figure 45. Europe Vigabatrin Sales Share by Country (2017-2028)
Figure 46. Europe Vigabatrin Revenue Share by Country (2017-2028)
Figure 47. Germany Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 48. France Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Vigabatrin Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Vigabatrin Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Vigabatrin Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Vigabatrin Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Vigabatrin Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Vigabatrin Revenue Share by Region (2017-2028)
Figure 58. China Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 61. India Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Vigabatrin Sales Market Share by Type (2017-2028)
Figure 68. Latin America Vigabatrin Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Vigabatrin Sales Market Share by Application (2017-2028)
Figure 70. Latin America Vigabatrin Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Vigabatrin Sales Share by Country (2017-2028)
Figure 72. Latin America Vigabatrin Revenue Share by Country (2017-2028)
Figure 73. Mexico Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Vigabatrin Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Vigabatrin Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Vigabatrin Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Vigabatrin Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Vigabatrin Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Vigabatrin Revenue Share by Country (2017-2028)
Figure 82. Turkey Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 85. Vigabatrin Value Chain
Figure 86. Vigabatrin Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
